As I’ve mentioned previously, a $5,000 investment once a year over a long enough period of time has the potential to grow into something significant due to the power of compounding interest.
Based on the average return of 9.1% per annum, an investment of $5,000 each year for a period of 30 years would grow to be worth approximately $760,000.
I believe this demonstrates just how rewarding long-term buy and hold investing can be.
With that in mind, here are three shares to buy with that first $5,000:
A2 Milk Company Ltd (ASX: A2M)
I think that this infant formula and fresh milk company would be a great investment option. Although its shares have been on a stellar run over the last 12 months, I don’t believe it is too late to invest due to its strong long-term growth potential thanks to its international expansion and increasing demand for its products in the massive China market. It was largely because of the latter that a2 Milk Company recently reported a 42% increase in revenue for the first nine months of FY 2019 compared to the prior corresponding period.
Cochlear Limited (ASX: COH)
According to the WHO, an estimated 524 million people were aged 65 or over in 2010. This equated to 8% of the global population. By 2050, this number is expected to nearly triple to around 1.5 billion, representing 16% of the global population. I think this is a major positive for Cochlear and is likely to result in increasingly strong demandfor its hearing solutions products over the next few decades, underpinning solid earnings growth. Because of this, I think it would be a great place to invest that $5,000.
Nanosonics Ltd (ASX: NAN)
Another top option in the healthcare sector could be this infection control specialist. Nanosonics is best-known for its trophon EPR product, which is a best in class disinfection system for ultrasound probes. Due to the quality of its product the company has been growing its installed base at a very strong rate over the last few years. This has led to strong sales of units and the consumables that the system requires to function. Pleasingly, I believe the company is well-positioned for further strong growth thanks to the sizeable market opportunity for its trophon EPR product and the upcoming launch of several new products targeting unmet needs.
And if you have another $5,000 left to invest then check out these dirt cheap ASX shares that have been rated as buys.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
Stock #1 is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Stock #2 is another high-growth business trading near a 52-week low all while offering a 4.7% grossed-up yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and Nanosonics Limited. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended Cochlear Ltd. and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.